J&J Unit Eyed Over Clinical Reviewers
The request by New Jersey Attorney General Anne Milgram was sent in May, the pharmaceutical giant revealed in a filing Tuesday with the U.S. Securities and Exchange Commission, without disclosing any further details.
This is not the first time DePuy has had a run-in with the authorities.
In March 2005, the...
To view the full article, register now.